Bladder Carcinoma Samples
In this category we offer human serum samples from donors with Malignant neoplasm of the Lateral wall and the Overlapping lesion of bladder. For normal control groups please switch to the category Healthy Donors. Please open the detailed product description for further information. If you do not find the research samples you are looking for, please contact us.
77 Products
Human Serum - C68.0
- Donor:
- Gender: Female Age: 87
- Diagnosed disease:
- C68.0 - Malignant neoplasm of urethra
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2)
Donor:
- Gender:
- Female
- Age:
- 87 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of urethra [C68.0]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: < 5.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: Euroimmun Analyzer EUROIMMUN AG |
| Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 10.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH296959
1 mL (€50.00)
Human Serum - Lactate dehydrogenase (LDH) - C67.8
- Donor:
- Gender: Female Age: 53
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Lactate dehydrogenase (LDH)
Donor:
- Gender:
- Female
- Age:
- 53 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Lactate dehydrogenase (LDH) |
Qual: positive
Quant: 5.37 µmol/s/L
Source: this donation
|
< 4.16 µmol/s/L
|
Method: Photometry System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167207
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 71
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 71 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 1.51 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167268
0.5 mL (€81.25)
Human Serum - C67.8
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 74 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Preanalytics:
- Details:
- centrifugation (10 min, 2500 x g = 3255 rpm, 20°C)
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: negative
Quant: 0.34 ng/mL
Source: this donation
|
< 4.4 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167273
0.5 mL (€81.25)
Human Citrate plasma - D-Dimer - C67.8
- Donor:
- Gender: Male Age: 79
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- D-Dimer
Donor:
- Gender:
- Male
- Age:
- 79 Years
Sample:
- Matrix:
- Citrate plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| D-Dimer |
Qual: positive
Quant: 6.04 mg/l FEU
Source: this donation
|
< 0.49 mg/l FEU
|
Method: Turbidimetry System: STA-R Evolution Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH176402
1.3 mL (€32.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 73
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 73 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.57 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH312470
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 72
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 72 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.56 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH94783
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 78
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 78 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.94 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156097
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 76
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 76 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.57 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156318
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Female Age: 84
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 84 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.69 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH311586
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Female Age: 83
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 83 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.73 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH311575
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 61
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 61 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.75 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH163769
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.1
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C67.1 - Malignant neoplasm of dome of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 82 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of dome of bladder [C67.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.58 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107439
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 67
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 67 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107935
0.9 mL (€33.75)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.1
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C67.1 - Malignant neoplasm of dome of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 82 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of dome of bladder [C67.1]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.55 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH107474
0.9 mL (€33.75)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 71
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 71 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 8.01 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307616
0.5 mL (€37.50)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 66
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 66 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- slightly hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 4.72 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307596
0.5 mL (€37.50)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 59
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 59 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 4.95 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307606
0.5 mL (€37.50)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.2
- Donor:
- Gender: Male Age: 72
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 72 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 8.15 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156392
0.5 mL (€37.50)
Human Serum - Prostate specific antigen (PSA), total - C67.2
- Donor:
- Gender: Male Age: 72
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 72 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 8.15 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156391
0.5 mL (€37.50)
Human EDTA plasma - Prostate specific antigen (PSA), total - C67.8
- Donor:
- Gender: Male Age: 66
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Prostate specific antigen (PSA), total
Donor:
- Gender:
- Male
- Age:
- 66 Years
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Prostate specific antigen (PSA), total |
Qual: positive
Quant: 8.19 ng/mL
Source: this donation
|
< 4.40 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH156376
0.5 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 83
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 83 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.31 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH162497
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 62
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 62 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.77 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH162507
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 73
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 73 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 3.41 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH301172
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 2.56 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH301191
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.54 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH301193
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Female Age: 69
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Female
- Age:
- 69 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 0.55 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294852
1 mL (€37.50)
Human K3EDTA plasma - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 61
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 61 Years
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.25 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294851
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C67.2
- Donor:
- Gender: Male Age: 68
- Diagnosed disease:
- C67.2 - Malignant neoplasm of lateral wall of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 68 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of lateral wall of bladder [C67.2]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.07 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH301196
1 mL (€37.50)
Human Serum - Procalcitonin (PCT) - C67.8
- Donor:
- Gender: Male Age: 55
- Diagnosed disease:
- C67.8 - Malignant neoplasm of overlapping lesion of bladder
- Parameter:
- Procalcitonin (PCT)
Donor:
- Gender:
- Male
- Age:
- 55 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of overlapping lesion of bladder [C67.8]
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Procalcitonin (PCT) |
Qual: positive
Quant: 1.00 ng/mL
Source: this donation
|
< 0.50 ng/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: cobas 8000 / e 801 Roche Measured in: serum |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH301279
1 mL (€37.50)
